Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot #1199.214: A double blind, randomised, placebo-controlled trial evaluating efficacy and safety of oral nintedanib treatment for at least 52 weeks in patients with ‘Systemic Sclerosis associated Interstitial Lung Disease’(SSc-ILD)
Dematte D'Amico, Jane E
(PD/PI)
Medicine, Pulmonary Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
2/11/16
→
11/30/21
Funding
Boehringer Ingelheim Pharmaceuticals, Inc.
(Prot #1199.214)
View all
View less